Financing type:  non-brokered private placement

Gross proceeds:  $17-million

Offering:  21.25 million common listed shares with 21.25 million warrants

Offering price:  80 cents per listed share

Warrant exercise terms:  $1.20 per listed share for a two-year period, subject to an acceleration right

Commissions in securities:  nil

Disclosure:  Refer to the company's news releases dated Nov. 18, 2025, Nov. 21, 2025, Nov. 24, 2025, Dec. 12, 2025, and Dec. 19, 2025.